# FDA Inspection 909374 - Novo Nordisk A/S - 25a-B - October 10, 2014

Source: https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-25a-b/fdfdb519-3bb2-4a70-9cb0-87607bf74333
Source feed: FDA_Inspections

> FDA inspection 909374 of Novo Nordisk A/S - 25a-B, October 10, 2014. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 909374
- Company Name: Novo Nordisk A/S - 25a-B
- Inspection Date: 2014-10-10
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1223821 - 2023-11-07](https://www.keypedia.com/records/fda_inspections/novo-nordisk-as-25a-b/1311c640-239f-42db-a99a-a4b693406f50)
- FDA Inspection 1207487 - 2022-11-04
- FDA Inspection 1118196 - 2018-06-14
- FDA Inspection 957571 - 2016-01-22
- FDA Inspection 933969 - 2015-06-18

Company: https://www.keypedia.com/companies/novo-nordisk-as-25a-b/017e6784-9871-4c62-9884-314e60ba61b7

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c